Back
Eagle Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
40
EGRX
Eagle Pharmaceuticals
Last Price:
4.54
Seasonality Move:
7.18%
Sell
14
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-7.96%
Sell
40
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $4.54. The Score for EGRX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $4.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 47.08 | Sell |
| Chaikin Money Flow: | -93784 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.28 - 4.84) | Sell |
| Bollinger Bands (100): | (4.55 - 5.83) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 38.85 | Sell |
| Chaikin Money Flow: | -1654308 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.09) | Buy |
| Bollinger Bands (100): | (0.1 - 0.18) | Sell |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.53 | Buy |
| 20-day SMA: | 4.5 | Buy |
| 50-day SMA: | 5.08 | Sell |
| 200-day SMA: | 9.53 | Sell |
| 8-day EMA: | 4.55 | Sell |
| 20-day EMA: | 4.58 | Sell |
| 50-day EMA: | 4.96 | Sell |
| 200-day EMA: | 9.85 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.08 | Sell |
| 50-day SMA: | 0.11 | Sell |
| 200-day SMA: | 0.3 | Sell |
| 8-day EMA: | 0.09 | Sell |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.11 | Sell |
| 200-day EMA: | 0.52 | Sell |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Eagle Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||